Gmax Biopharm LLC.
Industry
- Biotechnology
- Pharmaceuticals
- Vaccines
See more in Biomedtracker
Latest on Gmax Biopharm LLC.
Scrip
• By Xu Hu
With some Phase III clinical and real-world evidence showing superior effects on HbA1c reduction in type 2 diabetes and on weight loss for GLP-1/GIP analogs, such as Eli Lilly and Company ’s tirzepat
Scrip
• By Ian Haydock, Jung Won Shin, Lisa Takagi, Dexter Jie Yan, Anju Ghangurde, and Joseph Haas
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Daewoong, HanAll Co-Invest In Vinc
Scrip
• By Ayisha Sharma
Idorsia Pharmaceuticals Ltd and Johnson & Johnson ’s aprocitentan has succeeded in a Phase III resistant hypertension trial with plans in place for a US filing by year end, which could see it become